共 23 条
Agomelatine Treatment of Major Depressive Disorder in Parkinson's Disease: A Case Series
被引:16
作者:
De Berardis, Domenico
[1
,2
]
Fornaro, Michele
[3
]
Serroni, Nicola
[1
]
Olivieri, Luigi
[1
]
Marini, Stefano
[1
,2
]
Moschetta, Francesco Saverio
[1
]
Srinivasan, Venkataramanujam
Assetta, Maurizio
[4
]
Valchera, Alessandro
[5
]
Salone, Anatolia
[2
]
Martinotti, Giovanni
[2
]
Onofrj, Marco
[6
]
Di Giannantonio, Massimo
[2
]
机构:
[1] Hosp G Mazzini, NHS, Dept Mental Hlth, Psychiat Serv Diag & Treatment, Teramo, Italy
[2] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy
[3] Univ Catania, Dept Sci Formaz, I-95124 Catania, Italy
[4] Hosp G Mazzini, UOC Neurol, Teramo, Italy
[5] Hermanas Hosp, Villa San Giuseppe Hosp, Ascoli Piceno, Italy
[6] Univ G DAnnunzio, Dept Neurosci & Imaging Neurol, Chieti, Italy
关键词:
ANHEDONIA;
MELATONIN;
EXPRESSION;
D O I:
10.1176/appi.neuropsych.12110286
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of Parkinson's disease (PD), and therefore, most PD patients receive antidepressant drugs. Agomelatine is a recently introduced antidepressant drug acting as an MT1/MT2 melatonergic receptor agonist and 5HT(2C)/5HT(2B) serotonergic antagonist. The aim of this case series was to evaluate the role of agomelatine in the treatment of MDD associated with PD.
引用
收藏
页码:343 / 345
页数:3
相关论文